DPD Linearization Complexity Reduction of Remote Radio Heads in C-RAN with Radio over Fiber Fronthaul

Radio-over-Fiber (RoF) is a suitable technology for efficiently developing the cloud-RAN concept in Fifth Generation (5G) deployments based on Long Term Evolution Advanced LTE-A. Distortion coming out from the radiofrequency (RF) power amplifier should be taken into account in order to achieve the desired performance at the base station. In this paper, a complexity reduction technique based on a variable degree polynomial predistorter is proposed. The obtained results show that it is possible to achieve a reduction of operations with a penalty of 1.6 dB in ACLR and negligible impact on the EVM

Minimization of Feedback Loop Distortions in Digital Predistortion of a Radio-Over-Fiber System with Optimization Algorithms

This article proposes the linearization of an intensity modulation/direct detection radio-over-fiber (RoF) link with feedback loop. The goal is to carry out the predistortion process in a real scenario, in which the output signals are a few kilometers far from the baseband unit (BBU). First, the feedback loop is considered ideal, so the output signals are captured at the remote radio head side. Then, the feedback loop is taken into account, and both the input and output signals are captured at the BBU side. Applying optimization algorithms, such as Fibonacci, Golden, or Powell, it is possible to seek the optimal attenuation value within only a few iterations, which minimizes the distortion of the feedback loop. Experiments are carried out in a RoF system with 10 and 25 km length fiber within the long-Term evolution (LTE) standard. Measured results show how with a proper choice of the attenuation it is possible to reach analogous results regarding to an ideal feedback loop in terms of adjacent channel power ratio, the output signal power and error vector magnitude

Efficiency enhancement by reconfigurable matching networks in LINC transmitters

This paper proposes the use of a transmitter based on a linear amplification with nonlinear components (LINC) architecture, in which the reconfigurable matching networks (RMNs) are included. By varying the RMN active cell number, it is possible to change the load impedance at the power amplifier (PA) output, improving the amplifier drain efficiency and therefore the efficiency of the whole system. A long-term evolution (LTE) downlink signal with a bandwidth of 1.4 MHz and a peak-to-average power ratio (PAPR) of 11.48 dB is applied in order to carry out the experiments. Results show that the use of the RMNs in a LINC architecture improves the efficiency at all tested frequencies, especially at 927 MHz reaching an enhancement of 36.50%. Regarding the distortion, the adjacent channel leakage ratio (ACLR) values increase in all cases, with an improvement of 3.5 dB at 958 MHz. Finally, in terms of error vector magnitude (EVM), the proposed architecture offers a value of 1.96% at 927 MHz

Identification of two novel mutations in CDHR1 in consanguineous Spanish families with autosomal recessive retinal dystrophy.

Inherited retinal dystrophies present extensive phenotypic and genetic heterogeneity, posing a challenge for patients' molecular and clinical diagnoses. In this study, we wanted to clinically characterize and investigate the molecular etiology of an atypical form of autosomal recessive retinal dystrophy in two consanguineous Spanish families. Affected members of the respective families exhibited an array of clinical features including reduced visual acuity, photophobia, defective color vision, reduced or absent ERG responses, macular atrophy and pigmentary deposits in the peripheral retina. Genetic investigation included autozygosity mapping coupled with exome sequencing in the first family, whereas autozygome-guided candidate gene screening was performed by means of Sanger DNA sequencing in the second family. Our approach revealed nucleotide changes in CDHR1; a homozygous missense variant (c.1720C > G, p.P574A) and a homozygous single base transition (c.1485 + 2T > C) affecting the canonical 5' splice site of intron 13, respectively. Both changes co-segregated with the disease and were absent among cohorts of unrelated control individuals. To date, only five mutations in CDHR1 have been identified, all resulting in premature stop codons leading to mRNA nonsense mediated decay. Our work reports two previously unidentified homozygous mutations in CDHR1 further expanding the mutational spectrum of this gene

Efecto de la suplementación con celobiosa en el agua de bebida y del nivel e fibra soluble del pienso sobre los parámetros de crecimiento en conejos en cebo

El objetivo de este trabajo fue estudiar el efecto que tiene suplementar el agua con dosis de celobiosa inferiores a 7,5 g/l, en gazapos alimentados con dos niveles de fibra soluble sobre los parámetros productivos en gazapos en crecimiento. Se utilizaron 3 niveles de celobiosa en agua: 0, 3,5 y 7,0 g/l NPC Cello-Oligo combinados con 2 niveles de fibra soluble en el pienso (BF: 8,2 vs. AF: 10,5% sobre MS). Se utilizaron 240 gazapos destetados a los 26 d de edad (40/tratamiento), parte de los cuáles se sacrificaron a los 39 d de edad (8/tratamiento), momento en el que se sustituyeron los piensos experimentales por un pienso común estándar. La celobiosa se retiró a los 42 d de edad. En el periodo de 26 a 39 d de edad, los gazapos alimentados con el mayor nivel de fibra soluble redujeron un 6,4% el consumo de pienso respecto aquéllos alimentados con el nivel bajo de fibra soluble (P = 0,002), por lo que redujeron su ganancia de peso en un 7,0% (P = 0,002). En este periodo la ganancia de peso y la eficacia alimenticia de los animales alimentados con un bajo nivel de fibra soluble y 3,5 g celobiosa/l aumentaron en comparación con el promedio del grupo control y el de la dosis de 7 g/l (PBF(0+7 vs. 3,5) = 0,004 y 0,012, respectivamente), resultando en un peso mayor a los 39 d de edad (PBF(0+7 vs. 3,5) = 0,004). Los tratamientos no afectaron la actividad específica de la sacarasa en el yeyuno a los 39 d de edad. En el periodo global del cebo, el incremento de celobiosa redujo linealmente la ingestión (P = 0,040), tendiendo a mejorar la eficacia alimenticia (P = 0,10). Los gazapos que recibieron 3,5 g celobiosa/l en combinación con el pienso BF ganaron más peso que los que recibieron la dosis 0 ó 7 g celobiosa/l (PBF(0+7 vs 3,5) = 0,019). Por el contrario, los animales que recibieron la concentración intermedia de celobiosa en combinación con el pienso AF ganaron menos peso (PAF(0+7 vs 3,5) = 0,035). El nivel de fibra soluble no afectó a los rendimientos productivos ni a la mortalidad durante todo el periodo de cebo 26 a 56 d, pero el aumento de la concentración de celobiosa tendió a disminuir linealmente la mortalidad en los animales del grupo BF (PBF(0 vs 3,5 vs 7) = 0,069), mientras que los del grupo AF y que recibieron la concentración intermedia de celobiosa la mortalidad tendió a ser más baja (PAF(0+7 vs 3,5) = 0,11)

Efecto del nivel de fibra soluble y de la suplementación con celobiosa sobre los rendimientos productivos en conejos en cebo

El objetivo de este trabajo fue estudiar el efecto de la fibra soluble y la suplementación de con celobiosa en agua sobre los rencimientos productivos del gazapo tras el destete. A los gazapos se les suministró dos piensos que difirieron en el nivel de fibra soluble (7,7 vs.15,2%, sobre MS) y tres concentraciones de celobiosa en agua (0,0,75 y 1,5 fl). Los piensos y la celobiosa se suministraron a gazapos desde el destete (34 d edad 781±88 g, 44 gazapos/pienso) hasta los 48 d edad

A Comprehensive Analysis of Choroideremia: From Genetic Characterization to Clinical Practice.

Choroideremia (CHM) is a rare X-linked disease leading to progressive retinal degeneration resulting in blindness. The disorder is caused by mutations in the CHM gene encoding REP-1 protein, an essential component of the Rab geranylgeranyltransferase (GGTase) complex. In the present study, we evaluated a multi-technique analysis algorithm to describe the mutational spectrum identified in a large cohort of cases and further correlate CHM variants with phenotypic characteristics and biochemical defects of choroideremia patients. Molecular genetic testing led to the characterization of 36 out of 45 unrelated CHM families (80%), allowing the clinical reclassification of four CHM families. Haplotype reconstruction showed independent origins for the recurrent p.Arg293* and p.Lys178Argfs*5 mutations, suggesting the presence of hotspots in CHM, as well as the identification of two different unrelated events involving exon 9 deletion. No certain genotype-phenotype correlation could be established. Furthermore, all the patients´ fibroblasts analyzed presented significantly increased levels of unprenylated Rabs proteins compared to control cells; however, this was not related to the genotype. This research demonstrates the major potential of the algorithm proposed for diagnosis. Our data enhance the importance of establish a differential diagnosis with other retinal dystrophies, supporting the idea of an underestimated prevalence of choroideremia. Moreover, they suggested that the severity of the disorder cannot be exclusively explained by the genotype

Predicting high risk of exacerbations in bronchiectasis: the E-FACED score

BACKGROUND: Although the FACED score has demonstrated a great prognostic capacity in bronchiectasis, it does not include the number or severity of exacerbations as a separate variable, which is important in the natural history of these patients. OBJECTIVE: Construction and external validation of a new index, the E-FACED, to evaluate the predictive capacity of exacerbations and mortality. METHODS: The new score was constructed on the basis of the complete cohort for the construction of the original FACED score, while the external validation was undertaken with six cohorts from three countries (Brazil, Argentina, and Chile). The main outcome was the number of annual exacerbations/hospitalizations, with all-cause and respiratory-related deaths as the secondary outcomes. A statistical evaluation comprised the relative weight and ideal cut-off point for the number or severity of the exacerbations and was incorporated into the FACED score (E-FACED). The results obtained after the application of FACED and E-FACED were compared in both the cohorts. RESULTS: A total of 1,470 patients with bronchiectasis (819 from the construction cohorts and 651 from the external validation cohorts) were followed up for 5 years after diagnosis. The best cut-off point was at least two exacerbations in the previous year (two additional points), meaning that the E-FACED has nine points of growing severity. E-FACED presented an excellent prognostic capacity for exacerbations (areas under the receiver operating characteristic curve: 0.82 for at least two exacerbations in 1 year and 0.87 for at least one hospitalization in 1 year) that was statistically better than that of the FACED score (0.72 and 0.78, P<0.05, respectively). The predictive capacities for all-cause and respiratory mortality were 0.87 and 0.86, respectively, with both being similar to those of the FACED. CONCLUSION: E-FACED score significantly increases the FACED capacity to predict future yearly exacerbations while maintaining the score’s simplicity and prognostic capacity for death